$376.61
0.02% yesterday
NYSE, Aug 12, 10:00 pm CET
ISIN
US8636671013
Symbol
SYK

Stryker Stock price

$376.61
-14.85 3.79% 1M
-9.02 2.34% 6M
+16.56 4.60% YTD
+51.41 15.81% 1Y
+153.49 68.79% 3Y
+186.43 98.03% 5Y
+273.48 265.18% 10Y
+324.21 618.67% 20Y
NYSE, Closing price Tue, Aug 12 2025
-0.06 0.02%

Key metrics

Basic
Market capitalization
$144.0b
Enterprise Value
$156.4b
Net debt
$12.4b
Cash
$2.5b
Shares outstanding
382.2m
Valuation (TTM | estimate)
P/E
49.9 | 27.9
P/S
6.0 | 5.8
EV/Sales
6.6 | 6.2
EV/FCF
38.9
P/B
6.8
Dividends
DPS
$3.24
Yield 1Y | 5Y
0.9% | 1.1%
Growth 1Y | 5Y
6.2% | 8.7%
Payout 1Y | 3Y
41.8% | 41.1%
Increased
15 Years
Financials (TTM | estimate)
Revenue
$23.8b | $25.0b
EBITDA
$6.0b | $7.2b
EBIT
$5.3b | $6.6b
Net Income
$2.9b | $5.2b
Free Cash Flow
$4.0b
Growth (TTM | estimate)
Revenue
11.4% | 10.8%
EBITDA
13.2% | 26.5%
EBIT
13.9% | 30.1%
Net Income
-15.4% | 72.1%
Free Cash Flow
43.6%
Margin (TTM | estimate)
Gross
64.6%
EBITDA
25.1% | 28.7%
EBIT
22.3%
Net
12.3% | 20.6%
Free Cash Flow
16.9%
Financial Health
Equity Ratio
48.0%
Return on Equity
14.5%
ROCE
13.6%
ROIC
-
Debt/Equity
0.7
More
EPS
$7.6
FCF per Share
$10.5
Short interest
1.3%
Employees
53k
Rev per Employee
$430.0k
Show more

Is Stryker a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Stryker Stock Analysis

Unlock Scores for Free

Analyst Opinions

37 Analysts have issued a Stryker forecast:

27x Buy
73%
10x Hold
27%

Analyst Opinions

37 Analysts have issued a Stryker forecast:

Buy
73%
Hold
27%

Financial data from Stryker

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
23,818 23,818
11% 11%
100%
- Direct Costs 8,427 8,427
10% 10%
35%
15,391 15,391
12% 12%
65%
- Selling and Administrative Expenses 7,928 7,928
12% 12%
33%
- Research and Development Expense 1,495 1,495
9% 9%
6%
5,968 5,968
13% 13%
25%
- Depreciation and Amortization 669 669
8% 8%
3%
EBIT (Operating Income) EBIT 5,299 5,299
14% 14%
22%
Net Profit 2,918 2,918
15% 15%
12%

In millions USD.

Don't miss a Thing! We will send you all news about Stryker directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Stryker Stock News

Neutral
GlobeNewsWire
5 days ago
BALTIMORE, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Longeviti Neuro Solutions, a neurotechnology company with a focus on innovative platform solutions for complex brain disorders, today announces the appointment of Tim Scannell, former President & COO of Stryker Corporation, as Chair of its Board of Directors. The company also reveals a $10 million strategic capital partnership with Soleus Capital to ...
Neutral
GlobeNewsWire
6 days ago
Portage, Michigan, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable October 31, 2025, to shareholders of record at the close of business on September 30, 2025, representing an increase of 5.0% versus the prior year and unchanged from the previous quarter.  About Stryker Stryker is a global lea...
Positive
The Motley Fool
11 days ago
Stryker (SYK) Q2 Revenue Jumps 11%
More Stryker News

Company Profile

Stryker Corp. engages in providing medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine. The Orthopaedics segment provides reconstructive and trauma implant systems. The Medsurg segment deals with surgical equipment and navigation systems, endoscopy, patient handling, and reprocessed medical devices. The Neurotechnology and Spine segment pertains to spinal implants and neurovascular products. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.

Head office United States
CEO Kevin Lobo
Employees 53,000
Founded 1941
Website www.stryker.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today